Automated pathogen detection using time-gated luminescence microscopy. A rapid and general means of in-situ pathogen identification would benefit the community by ensuring that appropriate treatments can be applied in the early stages of a disease. Patient prognosis is thereby improved and opportunities for multi-drug resistant organisms to arise are limited. Time-gated luminescence microscopy (TgM) exploits persistent luminescence to overcome autofluorescence, a serious problem in pathogen dete ....Automated pathogen detection using time-gated luminescence microscopy. A rapid and general means of in-situ pathogen identification would benefit the community by ensuring that appropriate treatments can be applied in the early stages of a disease. Patient prognosis is thereby improved and opportunities for multi-drug resistant organisms to arise are limited. Time-gated luminescence microscopy (TgM) exploits persistent luminescence to overcome autofluorescence, a serious problem in pathogen detection. Drug-resistant 'Golden Staph' (MRSA) will be used as the model organism to evaluate TgM efficacy. Ultimately however, TgM will be applied for the detection of tuberculosis, a highly contagious disease affecting the respiratory system of more than one-third of the world's population.Read moreRead less
DEEP DRILLING OF THE HUMAN PLASMA PROTEOME. Like turning out city lights lets you see the faint stars more clearly - removal of high abundance proteins from human biofluids allows quantum leaps in biomarker discovery. This project will develop products that remove the biggest obstacle in proteomics - high abundance proteins (city lights). Cheap, efficient and routine removal of abundant proteins will amplify the power of ?cutting edge? proteomic technologies in the discovery of novel biomarkers ....DEEP DRILLING OF THE HUMAN PLASMA PROTEOME. Like turning out city lights lets you see the faint stars more clearly - removal of high abundance proteins from human biofluids allows quantum leaps in biomarker discovery. This project will develop products that remove the biggest obstacle in proteomics - high abundance proteins (city lights). Cheap, efficient and routine removal of abundant proteins will amplify the power of ?cutting edge? proteomic technologies in the discovery of novel biomarkers. This is possible because undiscovered low copy number biomarkers (faint stars) exist in human diagnostic fluids at levels far lower than current proteomic array detection limits.Read moreRead less